# PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

> **NCT05524090** · — · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 223 (estimated)

## Conditions studied

- Pancreatic Cancer
- Locally Advanced Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma Non-resectable
- Chemotherapy Effect

## Interventions

- **OTHER:** Implementation - International best-practice care

## Key facts

- **NCT ID:** NCT05524090
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 223 (ESTIMATED)
- **Last updated:** 2022-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524090, "PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05524090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*